je.st
news
A Pediatric Endocrinologist's View Of MannKind's Afrezza
2015-11-05 13:08:14| Biotech - Topix.net
There have been many investment analyst opinions expressed about the coming success or failure of MannKind Corporation's new inhaled insulin, Afrezza. Sanofi , MannKind's pharmaceutical marketing partner, has invested millions of dollars in up front licensing fees, milestone payments, and Afrezza related costs in marketing and promotion.
Tags: view
pediatric
afrezza
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||